COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03372837
Brief Title: Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell Lymphoma

First Submitted : December 10, 2017
First Submitted that Met QC Criteria : December 10, 2017
First Posted : December 14, 2017

Last Update Submitted that Met QC Criteria : October 19, 2020
Last Update Posted : October 22, 2020